ARID1A and neoplasm: Finally, our functional data demonstrates that the FAS phenotype in cells with ARID1A loss is mediated through reduced accessibility and transcription of the FAS-regulating co-TF RUNX3. Yet, RUNX3 itself may have tumor suppressive function.